Navigation Links
Obio Pharmaceutical Announces Product Growth Strategy
Date:2/18/2009

HONG KONG, Feb. 18 /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd ("Obio"/ "the Company") announced its business growth ticket to the international pharmaceutical arena. With a strong product pipeline in drug development, backed up by strong international investors including Yangtze Ventures Limited (New World Group, Shui On Group, Tai Sang Land Properties Limited, Yu Hwa Chinese Products Group, YangtzeKiang Garment Manufacturing Company Limited), Avanta Capital, Group of prominent Swiss investors, Simplex Capital Fund (Korea based), Japanese investors Mr. Haruyoshi Taguchi and Mr. Takatoshi Nakamura, PE Lifestyle (HK) Limited (subsidiary of Singapore listed company -- Goldtron Limited), Obio is taking off and adopting more aggressive measures to drive the growth of the Company.

The research based emerging pharmaceutical company has just had a facelift by appointing seasoned pharmaceutical executives to the Board so as to further overhaul its research and development activities and heighten its competitive edge. External research collaborations will continue to be the pillars of the Company to boost innovations and confirm experimental data in the future.

Mr. Abraham Chan, Director of the Company, said on the press conference of the Company dated February 9, 2009, "Obio plans to reinforce the global development strategy by focusing its researches on the globally prevalent but underserved diseases such as diabetes and influenza."

Amongst the drug candidates in the portfolio relating to the influenza virus and life-style diseases, Obio has managed to get two drugs patented at present. Drug DC9703, which targets Diabetes II, has been granted patents in USA and South Africa. The Company has also successfully patented the AK20 in China, which treats Nonalcoholic Steatohepatitis (NASH/ nonalcoholic fatty liver disease).

Besides the two patented drugs, Obio has also discovered a
'/>"/>

SOURCE Obio Pharmaceutical Holdings Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Savient Pharmaceuticals to Hold Fourth Quarter and Year-End 2008 Results Conference Call on Thursday, February 26, 2009
2. Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan
3. Idenix Pharmaceuticals Reports Fourth Quarter and Year End Financial Results
4. TechniKroms Biopharmaceutical Equipment Operations to be Integrated With Asahi Kasei Medical
5. Genesis Pharmaceuticals Reports Results for the Second Quarter of its Fiscal Year 2009
6. Vion Pharmaceuticals Submits New Drug Application for Onrigin(TM)
7. Shengtai Pharmaceutical, Inc. Reports Second Quarter Fiscal 2009 Financial Results
8. Genesis Pharmaceuticals Announces Conference Call to Discuss Results for its Second Quarter of FY 2009
9. XTL Biopharmaceuticals Announces Appointment of David Grossman and Boaz Shweiger to Board of Directors
10. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
11. Tianyin Pharmaceutical Co., Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Wednesday, February 18, 2009 at 8:45 a.m. EST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... licensed to biotechnology firms has revealed early bottlenecks ... roadblocks, the researchers suggest that better communication of ... lead to faster commercialization down the road. , ... in university laboratories and licensed to biotechnology firms. ... have a high failure rate. But a new ...
(Date:8/20/2014)... High performance computing (HPC) will ... complete climate and Earth system model to address ... , Eight national laboratories, including Lawrence Livermore ... for Atmospheric Research, four academic institutions and one ... national laboratories include Argonne, Brookhaven, Lawrence Berkeley, Los ...
(Date:8/20/2014)... Not long ago, it was more or less ... in the development cycle – even after the final ... that, like many things GxP, expectations for early E&L ... drug sponsors have been required by authorities to provide ... I/II. It’s not only clinical trial material containers causing ...
(Date:8/20/2014)... 2014 GraphDB™ 6.0 ... improvements to the enterprise replication cluster, faster loading ... SOLR and Elasticsearch. This release happens to coincide ... triplestore – GraphDB™ was formerly known as OWLIM. ... only mature enterprise resilient RDF triplestore will also ...
Breaking Biology Technology:Early bottlenecks in developing biopharmaceutical products delay commercialization 2Early bottlenecks in developing biopharmaceutical products delay commercialization 3New Project Is the ACME of Addressing Climate Change 2New Project Is the ACME of Addressing Climate Change 3Are Extractable and Leachables going Phase-Appropriate? New Webinar Hosted by Xtalks 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 2Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 3Ontotext Improves Its RDF Triplestore, GraphDB™ 6.0: Enterprise Resilience, Faster Loading Speeds and Connectors to Full-Text Search Engines Top the List of Enhancements 4
... COLUMBIA, Md., Aug. 11 BP and Martek Biosciences Corporation (Nasdaq: ... Development Agreement (JDA) to work on the production of microbial oils ... operational capabilities to advance the development of a step-change technology for ... Under the terms of the multi-year agreement, Martek and BP ...
... , QUEBEC CITY, Aug. 11 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. ... biopharmaceutical company focused on endocrinology and oncology, today reported financial and ... ended June 30, 2009. , , , ... - Two poster presentations at the American Association of Cancer, ...
... , SANTA MONICA, Calif. and LAS VEGAS, ... one of the largest umbilical cord blood stem cell preservation companies ... the life saving potential of stem cells to families nationwide and ... square foot facility in Las Vegas for conversion into a state-of-the-art ...
Cached Biology Technology:BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 2BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 3BP and Martek Biosciences Enter a Joint Development Agreement to Deliver Advanced Biodiesels 4AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 2AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 3AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 4AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 5AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 6AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 7AEterna Zentaris Reports Second Quarter 2009 Financial and Operating Results 8Cord Blood America New Las Vegas Stem Cell Laboratory Scheduled for Opening in 4th Quarter 2009 2Cord Blood America New Las Vegas Stem Cell Laboratory Scheduled for Opening in 4th Quarter 2009 3
(Date:8/21/2014)... linked to dandruff, eczema and other itchy, flaky maladies ... global reachesincluding Hawaiian coral reefs and the extreme environments ... review in the scientific journal PLOS Pathogens ... of the genus Malassezia in light of ... around the world. , University of Hawai,i at Mānoa ...
(Date:8/21/2014)... AWI geologist Juliane Mller the Fram Strait is a key ... of this passage between Greenland and Svalbard warm Atlantic water ... the west side cold Arctic water masses and sea ice ... Atlantic. A considerable portion of the Atlantic water cools here ... layers. The circulation of the water caused in this manner ...
(Date:8/21/2014)... La. A team of researchers at ... method for using affordable, consumer-grade 3D printers ... that can contain antibacterial and chemotherapeutic compounds ... comprised of doctoral students and research faculty ... engineering programs collaborated to create filament extruders ...
Breaking Biology News(10 mins):From dandruff to deep sea vents, an ecologically hyper-diverse fungus 2Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3
... have identified a key step for the future prevention ... the everyday painkiller paracetamol (also known as acetaminophen). ... Academy of Sciences ( PNAS ), the study ... potentially lethal consequences of paracetamol overdose. "Paracetamol is ...
... Robotics is becoming a transformative technology. We ... of robotics to examine how the increasing sophistication of ... to hospitals, to public spaces, and even to the ... various policy issues. "We Robot 2014: Risks ...
... movies or played with toy Transformers, those shape-shifting machines ... It turns out that DNA-repair machines in your cells ... diseases, according to research led by scientists from the ... Lab). As reported in a pair of new ...
Cached Biology News:Stopping liver failure from painkiller overdose 2We Robot 2014 April 4th & 5th at University of Miami School of Law 2How a shape-shifting DNA-repair machine fights cancer 2How a shape-shifting DNA-repair machine fights cancer 3
... Protein Purification Plates are designed for quick ... The 96-well plates feature two 0.25mm holes ... each well. The wells remain liquid-tight during ... during which time the protein diffuses from ...
... the state-of-the-art in permanent mounting media. ... preservation of immunohistochemical organic insoluble substrates ... New Fuchsin, and any other organic ... sections. Clarin can be used for ...
... industry's first siRNA sequence design software in ... these tools consistent with new experimental strategies ... of RNAi. With the introduction of ... tools, OligoEngine is pleased to offer the ...
... been designed and created in order to ... genotyping analysis tool. We incorporated the suggestions ... the software. Their main requirements were ease- ... acquisition cost. GeneMarker can perform analysis ...
Biology Products: